Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S. Topp, Hagop M. Kantarjian, Robin Foà et al.|The Lancet Oncology|2014Cited by 1.3k
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic LeukemiaPatrick A. Brown, Mignon L. Loh, Lingyun Ji et al.|JAMA|2021Cited by 358
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumoursGerhardt Attard, Maja J.A. de Jonge, Jos Kitzen et al.|British Journal of Cancer|2007Cited by 71
A phase Ib study of pertuzumab (P), a recombinant humanized antibody to HER2, and docetaxel (D) in patients (pts) with advanced solid tumorsGerhardt Attard, Maja J. De Jonge, Jos Kitzen et al.|Journal of Clinical Oncology|2005Cited by 8
Single-Agent Subcutaneous Blinatumomab for Advanced B-Cell Acute Lymphoblastic Leukemia: Long-Term Follow-up from a Phase 1b Dose Expansion CohortElias Jabbour, Hagop M. Kantarjian, Gerhard Zugmaier et al.|Blood|2024Cited by 3